Corticosteroid – Page 9 – Communicable Diseases Research

Comparison of Outcomes and Process of Care for Patients Treated at Hospitals Dedicated for COVID-19 Care vs Other Hospitals

Research

Published on 2022-03-032022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation

COVID-19 중환자 환자의 2 차 감염 : 후 향적 단일 센터 평가

Observational Study

Published on 2022-03-022022-09-10
Journal: BMC Infectious Diseases [Category] MERS, SARS, 임상, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus administration of corticosteroid Admission adult COVID-19 patient aggravate Bacteremia Bacterial infection Bacterial infections Belgium bloodstream infection Bloodstream infections catheter caused cocci Combination coronavirus Corticosteroid Corticosteroids COVID-19 COVID-19 patient COVID-19 patients Critically ill critically ill COVID-19 patients Critically ill patient critically ill patients Culture cultures cumulative Cumulative Dose database develop diabetes Diabetes Mellitus dose eligible for inclusion Gender gram group higher risk highest ICU identify Immunosuppression incidence increased risk Infection intensive care intensive care unit Observational cohort study pathogen Pathogens Patient patients Pneumonia proportion Research Result resulting retrospective retrospective observational cohort study risk risk factor risk of death SARS-CoV-2 secondary bacterial infection Secondary bacterial infections Secondary infection secondary infections secondary pneumonia Sepsis severe acute respiratory syndrome Coronavirus severity severity of illness single-center supplementary material susceptible virus Virus Disease was performed
[DOI] 10.1186/s12879-022-07192-x PMC 바로가기 [Article Type] Observational Study

Mortality and associated risk factors in patients hospitalized due to COVID-19 in a Peruvian reference hospital

Research Article

Published on 2022-03-022022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

[키워드] 95% CI 95%CI Adjusted analysis adjusted hazard ratio Admission age alteration biochemical Clinical characteristics Cohort cohort study Comorbidity Corticosteroid COVID-19 Cox regression model determine dose evaluate Factors general condition hematological high mortality hospital Hospitalization Hospitalized hypertension in-hospital mortality independent variable IQR Ivermectin laboratory result leukocyte lower mortality lower oxygen saturation male median medical record moderate Mortality mortality rate National obesity objective outcomes oxygen saturation patients patients hospitalized patients with COVID-19 Physical examination Result risk factor Sociodemographic Treatment type 2 diabete use of corticosteroid use of hydroxychloroquine was used
[DOI] 10.1371/journal.pone.0264789 PMC 바로가기 [Article Type] Research Article

Can FeNO be a biomarker in the post-COVID-19 patients monitoring?

FeNO는 코로나19 이후 환자 모니터링에서 바이오마커가 될 수 있습니까?

Article

Published on 2022-03-012022-09-11
Journal: Respiratory medicine [Category] MERS, SARS, 바이오마커,

Pattern of medication utilization in hospitalized patients with COVID-19 in three District Headquarters Hospitals in the Punjab province of Pakistan

Research article

Published on 2022-03-012022-10-05
Journal: Exploratory Research in Clinical and Social Pharmacy [Category] 신약개발, 치료제,

Clinical outcomes of corticosteroids for COVID-19 patients at the National Center for Global Health and Medicine during the first wave of infections

Research article

Published on 2022-03-012022-10-05
Journal: Respiratory investigation [Category] SARS, 임상,

[키워드] acute respiratory syndrome Admission both groups caused center Characteristics clinical Clinical course Clinical efficacy collected data condition coronavirus Coronavirus disease 2019 Corticosteroid corticosteroid therapy Corticosteroids COVID-19 COVID-19 patient Critically ill patient Dexamethasone diagnosed with COVID-19 examined Fever First wave global health hospital ill patients Infection infections Japan medical record Medicine mortality rate no difference no statistical difference outbreak outcome Patient patients with COVID-19 polymerase chain Primary outcome reduced Result SARS-CoV 2 seven-category ordinal scale severely ill patient treated Treatment two group with COVID-19
[DOI] 10.1016/j.resinv.2021.11.001 [Article Type] Research article

Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients

Observational Study

Published on 2022-03-012022-10-04
Journal: European Journal of Hospital Pharmacy [Category] SARS, 임상,

[키워드] activities Admission Adverse adverse event age Anti-inflammatory Baricitinib C-reactive protein clinical clinical benefit Clinical improvement Corticosteroid COVID-19 Critical Critical care Cytokine storm syndrome education Effectiveness event Evidence-based medicine ferritin hospital discharge hospitalised hospitalised patient immunomodulator improvement inhibitor interleukin-6 IQR laboratory parameter limitation Lymphocytes men Patient Pharmacy Platelet poor prognosis pulmonary medicine Randomised trial reported Retrospective study risk factor severe COVID-19 survival Time to recovery treated Treatment viral endocytosis Virology
[DOI] 10.1136/ejhpharm-2021-002741 PMC 바로가기 [Article Type] Observational Study

Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study

Research article

Published on 2022-03-012022-10-05
Journal: The American journal of medicine [Category] 바이오마커, 유전자 메커니즘, 임상, 치료법,

[키워드] adjusted analyses African Americans biomarkers of inflammation black Black patient Black race both group C-reactive protein clinical trial clinical trials collected data consecutive patient contribute convalescent serum coronavirus coronavirus disease Corticosteroid Corticosteroids COVID-19 death described determine Diabetes Mellitus difference Disparities enrolled Enrollment higher odd Hospitalization Hospitalized hypertension In-hospital inflammatory markers Inflammatory response less M2C2 mechanical ventilation Mortality not significant obesity outcome patients patients hospitalized patients with COVID-19 prevalence of COVID-19 Prospective prospective cohort study Racial receive receptor Remdesivir renal replacement therapy Result risk factor SARS-CoV-2 Therapies
[DOI] 10.1016/j.amjmed.2021.10.026 [Article Type] Research article

Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids A Bayesian Reanalysis of a Previous Meta-analysis

토실리주맙 및 코르티코스테로이드로 치료받은 COVID-19 감염 입원 환자의 사망률 이전 메타 분석의 베이지안 재분석

Meta-Analysis

Published on 2022-02-282022-09-12
Journal: JAMA Network Open [Category] MERS, 진단,

[키워드] age all-cause mortality Analysis association Bayesian Bayesian methods benefit Can Care clinically concerning Corticosteroid Corticosteroids country COVID-19 credible interval CrI distributions evaluate evaluated finding Future greater Health Organization Hierarchical hospitalized patient hospitalized patients Importance IMV interval Invasive mechanical ventilation magnitude measure men Meta-analysis Mortality mortality risk NIV Noninvasive ventilation objective Odds ratio oxygen oxygen only participant Patient patients with COVID-19 Placebo Point posterior probability Probability randomization Randomized randomized clinical trial Rate receiving reduced Relevance Research Respiratory Support Result risk risk difference robustness setting subgroup subgroups survival the WHO Tocilizumab treated treatment with tocilizumab Trial usual care was performed WHO with COVID-19 World Health Organization
[DOI] 10.1001/jamanetworkopen.2022.0548 PMC 바로가기 [Article Type] Meta-Analysis

Mucormycosis infection in patients with COVID ‐19: A systematic review

Infectious Diseases

Published on 2022-02-282022-11-01
Journal: Health Science Reports [Category] COVID-19,